Mirror, Mirror on the Wall Who's the Most Ambitious Big Pharma Company of Them All?.
According to this post in the BioJobBlog it's Roche with its burgeoning pipeline and claims that it may file 10 INDs before the end of 2013. Certainly, they are a company that acts like an innovator and appears to want to focus its energies on creating new products in new therapuetic catagories to fulfill unmet patient need. Now they just have to avoid the poisoned apples.
Posted by Bruce Lehr December 12th 2010.
Comments